|
|
|
|
Global pharmacovigilance for antiretroviral drugs: Overcoming contrasting priorities
|
|
|
|
|
|
|
|
نویسنده
|
bakare n. ,edwards i.r. ,stergachis a. ,pal s. ,holmes c.b. ,lindquist m. ,duncombe c. ,dodoo a. ,novendstern j. ,nwokike j. ,kuchenbecker r. ,aberg j.a. ,miller v. ,strobos j.
|
|
منبع
|
plos medicine - 2011 - دوره : 8 - شماره : 7
|
|
چکیده
|
[no abstract available]
|
|
|
|
|
آدرس
|
forum for collaborative hiv research,johns hopkins bloomberg school of public health,baltimore,md,united states,j and j pharmaceuticals research and development,titusville,nj, United States, who collaborating centre for international drug monitoring,uppsala, Sweden, school of public health,university of washington,seattle,wa, United States, quality assurance and safety: medicines,department of essential medicines and pharmaceutical policies,world health organization,geneva, Switzerland, us department of state,washington,d.c., United States, who collaborating centre for international drug monitoring,uppsala, Sweden, department of hiv/aids,world health organization,geneva, Switzerland, who collaborating centre for advocacy and training in pharmacovigilance,university of ghana medical school,accra, Ghana, ranbaxy inc.,princeton,nj, United States, management sciences for health,strengthening pharmaceutical systems (sps) programs,arlington,va, United States, graduate studies program in epidemiology,federal university of rio grande do sul,hospital de clinicas de porto alegre,porto alegre,brazil,brazilian national institute of science and technology for health technology assessment (iats cnpq),porto alegre, Brazil, new york university school of medicine,new york,ny, United States, forum for collaborative hiv research,washington,d.c., United States, forum for collaborative hiv research,washington,d.c., United States
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|